Dl-NBP (Dl-3-N-Butylphthalide) Treatment Promotes Neurological Functional Recovery Accompanied by the Upregulation of White Matter Integrity and HIF-1α/VEGF/Notch/Dll4 Expression

Dl-3-n-butylphthalide (dl-NBP) was approved by the FDA of China for the treatment of acute ischemic stroke. Dl-NBP has been shown to promote neurological functional recovery and enhance white matter integrity using an endothelin-1-induced focal permanent cerebral ischemia model, which could mimic th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanping, Shen, Yufei, Liu, Ziyun, Gu, Jingxia, Xu, Congying, Qian, Shuxia, Zhang, Xiaoling, Zhou, Beiqun, Jin, Yuhua, Sun, Yanyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993069/
https://www.ncbi.nlm.nih.gov/pubmed/32038259
http://dx.doi.org/10.3389/fphar.2019.01595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993069/
https://www.ncbi.nlm.nih.gov/pubmed/32038259
http://dx.doi.org/10.3389/fphar.2019.01595

Ejemplares similares